New drug shows promise against several aggressive cancers
A new phase I/II open-label, dose-escalation trial has recently tested the effectiveness of a “Trojan horse” drug in treating multiple types of otherwise treatment-resistant cancer in its late stages. Published Wednesday 13 February 2019 By...
Read More